Bionomics Limited
BNOEF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$9,907 | -$378,146 | $11,262 | -$1,943 |
| Dep. & Amort. | $166 | $662,393 | $165 | $166 |
| Deferred Tax | $0 | -$468,427 | $0 | $0 |
| Stock-Based Comp. | $0 | $163,706 | $20 | $19 |
| Change in WC | $1,397 | $2,170 | -$643 | -$328 |
| Other Non-Cash | $4,549 | $91,871 | $649 | -$1,272 |
| Operating Cash Flow | -$3,795 | $73,567 | $11,453 | -$3,358 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $3,254 | -$794 | $824 | -$107 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $1,528,242 | $339 | $0 |
| Financing Cash Flow | $3,254 | $1,527,448 | $1,163 | -$107 |
| Forex Effect | -$2,776 | -$3,696 | $85 | -$277 |
| Net Chg. in Cash | -$3,317 | $14,271,571 | $12,701 | -$3,746 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $17,045 | $17,119 | $4,419 | $8,165 |
| End Cash | $13,728 | $14,288,690 | $17,119 | $4,419 |
| Free Cash Flow | -$3,795 | $73,567 | $11,453 | -$3,358 |